keyword
MENU ▼
Read by QxMD icon Read
search

Proton pump inhibitors

keyword
https://www.readbyqxmd.com/read/29925065/impact-of-laparoscopic-repair-of-large-hiatus-hernia-on-quality-of-life-observational-cohort-study
#1
Stefano Siboni, Emanuele Asti, Pamela Milito, Gianluca Bonitta, Andrea Sironi, Alberto Aiolfi, Luigi Bonavina
BACKGROUND: Laparoscopic surgery has proven safe and effective in the treatment of large hiatus hernia. Differences may exist between objectively assessed surgical outcomes, symptomatic scores, and patient-reported outcomes. METHODS: An observational, single-arm cohort study was conducted in patients undergoing primary laparoscopic repair with crura mesh augmentation and Toupet fundoplication for large (> 50% of intrathoracic stomach) type III-IV hiatus hernia...
June 20, 2018: Digestive Surgery
https://www.readbyqxmd.com/read/29923251/use-of-proton-pump-inhibitors-and-risk-of-pancreatic-cancer
#2
Blánaid Hicks, Søren Friis, Anton Pottegård
PURPOSE: Preclinical studies have suggested that proton pump inhibitors (PPIs) may increase pancreatic cancer risk; however, epidemiological studies are few, with conflicting results. This spurred us to evaluate whether PPI use is associated with an increased risk of pancreatic cancer in a large population-based study. METHODS: We conducted a nationwide case-control study using data from Danish demographic and health care registries. All patients with a first cancer diagnosis of pancreatic cancer between 2000 and 2015 were identified from the Danish Cancer Registry and age-matched, sex-matched, and calendar-matched 1:20 to population controls using risk set sampling...
June 20, 2018: Pharmacoepidemiology and Drug Safety
https://www.readbyqxmd.com/read/29922412/a-prospective-cross-sectional-study-of-detection-of-clostridium-difficile-toxin-in-patients-with-antibiotic-associated-diarrhoea
#3
Arun Sachu, Kavitha Dinesh, Ismail Siyad, Anil Kumar, Anu Vasudevan, Shamsul Karim
Background and Objectives: Clostridium difficile infections (CDI) include self-limiting antibiotic associated diarrhoea (AAD), antibiotic-associated colitis, and pseudomembranous colitis. The present study aimed at detecting C. difficile toxin in stool samples of patients with AAD and analyzing the antibiotic use and presence of other risk factors in these patients. Materials and Methods: In this study, which was conducted on 660 samples, a 2- step strategy was used...
February 2018: Iranian Journal of Microbiology
https://www.readbyqxmd.com/read/29915630/once-versus-twice-daily-oral-proton-pump-inhibitor-therapy-for-prevention-of-peptic-ulcer-rebleeding-a-propensity-score-matched-analysis
#4
Fares Ayoub, Vikas Khullar, Debdeep Banerjee, Patrick Stoner, Tiffany Lambrou, Donevan R Westerveld, Wissam Hanayneh, Amir Y Kamel, David Estores
Background: After inpatient management of upper gastrointestinal bleeding (GIB) due to peptic ulcer disease (PUD), oral proton pump inhibitor (PPI) therapy is recommended at discharge to decrease rebleeding risk and improve ulcer healing. Our aim is to determine whether once-daily oral PPI dosing at hospital discharge is associated with inferior 30-day rebleeding outcomes as compared to twice-daily dosing. Methods: We retrospectively identified 233 patients admitted with signs and symptoms of upper GIB found to be due to PUD on upper endoscopy...
June 2018: Gastroenterology Research
https://www.readbyqxmd.com/read/29915629/possible-risk-factors-for-candida-esophagitis-in-immunocompetent-individuals
#5
Yousef Nassar, Tony Eljabbour, Hwajeong Lee, Asra Batool
Background: Candida esophagitis (CE) is a condition typically diagnosed in patients who are immunocompromised. Risk factors leading to the development of CE in immunocompetent patients have not been entirely elucidated. This study set out to identify risk factors associated with the development of CE in immunocompetent patients. Methods: This study was a single-center retrospective chart review. Patients diagnosed with CE confirmed by endoscopic biopsy or brushings at our hospital between 2007 and 2017 were reviewed...
June 2018: Gastroenterology Research
https://www.readbyqxmd.com/read/29915626/novel-surgical-treatments-for-gastroesophageal-reflux-disease-systematic-review-of-magnetic-sphincter-augmentation-and-electric-stimulation-therapy
#6
REVIEW
Michal Stanak, Judit Erdos, Katharina Hawlik, Tudor Birsan
Electric stimulation therapy (EST) and magnetic sphincter augmentation (MSA) represent novel methods for the surgical treatment of gastroesophageal reflux disease (GERD). The aim of this review was to assess the effectiveness and safety of EST and magnetic sphincter augmentation device (MSAD) comapred to laparoscopic fundoplication (LF) and proton pump inhibitor therapy (in case of EST). We performed a systematic literature search without restrictions on publication dates in five electronic databases (MEDLINE, EMBASE, the Cochrane library, PubMed, and Centre for Reviews and Dissemination), complemented by hand search, search in trial registries, and documentation provided by the manufacturers...
June 2018: Gastroenterology Research
https://www.readbyqxmd.com/read/29913281/most-patients-with-gastroesophageal-reflux-disease-who-failed-proton-pump-inhibitor-therapy-also-have-functional-esophageal-disorders
#7
Jason Abdallah, Nina George, Takahisa Yamasaki, Stephen Ganocy, Ronnie Fass
BACKGROUND & AIMS: As many as 45% of patients with gastroesophageal reflux disease (GERD) still have symptoms after receiving once-daily proton pump inhibitor (PPI) therapy. We aimed to compare reflux characteristics and patterns between responders and non-responders to once-daily PPI therapy using combined impedance-pH monitoring. METHODS: Patients who reported heartburn and/or regurgitation at least twice per week for 3 months while receiving standard-dose PPI therapy were assigned to the PPI failure group (n=16)...
June 15, 2018: Clinical Gastroenterology and Hepatology
https://www.readbyqxmd.com/read/29912581/posaconazole-in-immunocompromised-pediatric-patients
#8
Edoardo Bruno Vicenzi, Simone Cesaro
INTRODUCTION: Posaconazole is a broad-spectrum triazole widely used to prevent and treat invasive mycoses in adults. Since it received marketing authorization more than a decade ago, many authors have reported on its off-label use in pediatric patients, despite the fact that the pharmacokinetics, safety and efficacy in children have not been extensively investigated. AREAS COVERED: We reviewed pediatric studies published between 2010 and 2017 describing the prophylactic and therapeutic use of posaconazole, with special attention to the correlation between oral dose, plasma levels, safety, and effectiveness...
June 18, 2018: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/29910147/cameron-lesions-a-still-overlooked-diagnosis-case-report-and-systematic-review-of-literature
#9
A Zullo, R Manta, V De Francesco, G Fiorini, E Lahner, D Vaira, B Annibale
Cameron lesions are erosive-ulcerative alterations of gastric mucosa occurring in patients with large hiatal hernia, potentially causing gastrointestinal bleeding and iron deficiency anaemia. Diagnosis may be challenging, and not infrequently erosions are overlooked at endoscopy, so that repeated and unnecessary diagnostic procedures are performed, particularly in those patients with chronic anaemia. We described two peculiar cases of patients with iron deficiency anaemia in whom Cameron lesions were either overlooked or misinterpreted...
June 14, 2018: Clinics and Research in Hepatology and Gastroenterology
https://www.readbyqxmd.com/read/29909660/-effectivity-of-the-nissen-fundoplication-and-the-influencing-factors-of-the-success-results-at-the-medical-centre-of-p%C3%A3-cs-depending-on-the-indications-and-symptoms
#10
Péter Varjú, Örs Péter Horváth, András Papp, Noémi Gede, József Czimmer
INTRODUCTION: Gastroesophageal reflux disease is one of the most common gastrointestinal diseases in developed countries. Besides the conservative modalities, surgery plays an increasing role in the treatment of the disease. AIM: Our aim was to investigate and compare the surgical and 6-month follow-up data of patients to the literature (quality control), who underwent Nissen fundoplication in the Medical Centre of Pécs between 2007 and 2014, and to assess the factors (especially psychiatric comorbidity and antidepressants) influencing the success...
June 2018: Orvosi Hetilap
https://www.readbyqxmd.com/read/29904244/treatment-of-helicobacter-pylori-infection-in-atrophic-gastritis
#11
REVIEW
Edith Lahner, Marilia Carabotti, Bruno Annibale
Helicobacter pylori (Hp) is a major human pathogen causing chronic, progressive gastric mucosal damage and is linked to gastric atrophy and cancer. Hp-positive individuals constitute the major reservoir for transmission of infection. There is no ideal treatment for Hp. Hp infection is not cured by a single antibiotic, and sometimes, a combined treatment with three or more antibiotics is ineffective. Atrophic gastritis (AG) is a chronic disease whose main features are atrophy and/or intestinal metaplasia of the gastric glands, which arise from long-standing Hp infection...
June 14, 2018: World Journal of Gastroenterology: WJG
https://www.readbyqxmd.com/read/29900874/dabigatran-in-patients-with-myocardial-injury-after-non-cardiac-surgery-manage-an-international-randomised-placebo-controlled-trial
#12
P J Devereaux, Emmanuelle Duceppe, Gordon Guyatt, Vikas Tandon, Reitze Rodseth, Bruce M Biccard, Denis Xavier, Wojciech Szczeklik, Christian S Meyhoff, Jessica Vincent, Maria Grazia Franzosi, Sadeesh K Srinathan, Jason Erb, Patrick Magloire, John Neary, Mangala Rao, Prashant V Rahate, Navneet K Chaudhry, Bongani Mayosi, Miriam de Nadal, Pilar Paniagua Iglesias, Otavio Berwanger, Juan Carlos Villar, Fernando Botto, John W Eikelboom, Daniel I Sessler, Clive Kearon, Shirley Pettit, Mukul Sharma, Stuart J Connolly, Shrikant I Bangdiwala, Purnima Rao-Melacini, Andreas Hoeft, Salim Yusuf
BACKGROUND: Myocardial injury after non-cardiac surgery (MINS) increases the risk of cardiovascular events and deaths, which anticoagulation therapy could prevent. Dabigatran prevents perioperative venous thromboembolism, but whether this drug can prevent a broader range of vascular complications in patients with MINS is unknown. The MANAGE trial assessed the potential of dabigatran to prevent major vascular complications among such patients. METHODS: In this international, randomised, placebo-controlled trial, we recruited patients from 84 hospitals in 19 countries...
June 9, 2018: Lancet
https://www.readbyqxmd.com/read/29899438/complications-of-antireflux-surgery
#13
REVIEW
Rena Yadlapati, Eric S Hungness, John E Pandolfino
Antireflux surgery anatomically restores the antireflux barrier and is a therapeutic option for proton pump inhibitor (PPI)-refractory gastroesophageal reflux disease or PPI intolerance. Laparoscopic fundoplication is the standard antireflux surgery, though its popularity has declined due to concerns regarding wrap durability and adverse events. As the esophagogastric junction is an anatomically complex and dynamic area subject to mechanical stress, wraps are susceptible to disruption, herniation or slippage...
June 14, 2018: American Journal of Gastroenterology
https://www.readbyqxmd.com/read/29899426/efficacy-of-two-different-dosages-of-levofloxacin-in-curing-helicobacter-pylori-infection-a-prospective-single-center-randomized-clinical-trial
#14
Huo-Ye Gan, Tie-Li Peng, You-Ming Huang, Kai-Hua Su, Lin-Li Zhao, Li-Ya Yao, Rong-Jiao Yang
Bismuth + proton pump inhibitor (PPI) + amoxicillin + levofloxacin is one of the bismuth quadruple therapy regimens widely used for the eradication of H. pylori infection. The recommended dosage of levofloxacin is 500 mg once daily or 200 mg twice daily to eradicate H. pylori infection. The aim of the present open-label, randomized control trial was to compare the effectiveness, safety, and compliance of different dosages of levofloxacin used to cure Helicobacter pylori infection. Eligible patients were randomly assigned to receive esomeprazole, amoxicillin, colloidal bismuth pectin and levofloxacin 500 mg once/day (group A) or levofloxacin 200 mg twice/day (group B) for 14 days...
June 13, 2018: Scientific Reports
https://www.readbyqxmd.com/read/29898846/time-to-therapeutic-range-tttr-anticoagulation-control-and-cardiovascular-events-in-vitamin-k-antagonists-naive-patients-with-atrial-fibrillation
#15
Daniele Pastori, Pasquale Pignatelli, Francesco Cribari, Roberto Carnevale, Mirella Saliola, Francesco Violi, Gregory Yh Lip
BACKGROUND: Vitamin K antagonists (VKAs) reduce cardiovascular events (CVEs) in atrial fibrillation (AF) when a time in therapeutic range (TiTR) >70% is achieved. Factors affecting the time to achieve the TR (TtTR) are unknown. METHODS: Prospective observational study including 1,406 nonvalvular AF patients starting VKAs followed for a mean of 31.3months (3,690 patient/year); TiTR, TtTR, and SAMe-TT2 R2 score were calculated, and CVEs were recorded. RESULTS: Median TtTR was 8...
June 2018: American Heart Journal
https://www.readbyqxmd.com/read/29898576/clarithromycin-resistance-and-female-gender-affect-helicobacter-pylori-eradication-failure-in-chronic-gastritis
#16
Young Woon Chang, Weon Jin Ko, Chi Hyuk Oh, Yoo Min Park, Shin Ju Oh, Jung Rock Moon, Jun-Hyung Cho, Jung-Wook Kim, Jae-Young Jang
Background/Aims: The eradication rate of the first-line triple therapy (a proton pump inhibitor, clarithromycin, and amoxicillin) for Helicobacter pylori infection has gradually decreased in Korea. We evaluated whether clinical parameters, clarithromycin resistance, and CYP2C19 genotype can affect the eradication failure. Methods: A total of 203 patients with H. pylori-positive chronic gastritis were consecutively enrolled. They received clarithromycin-based triple therapy for 7 days...
June 14, 2018: Korean Journal of Internal Medicine
https://www.readbyqxmd.com/read/29897249/a-randomized-study-investigating-the-effect-of-omeprazole-on-the-pharmacokinetics-of-oral-semaglutide
#17
Tine A Bækdal, Astrid Breitschaft, Andrea Navarria, Cilie W Hansen
Background Since the first oral glucagon-like peptide-1 analog comprises semaglutide co-formulated with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC), which induces a transient, localized increase in gastric pH, we have investigated whether a proton pump inhibitor affects the pharmacokinetics of oral semaglutide. Research design and methods A single-center, randomized, open-label, parallel-group trial investigated pharmacokinetic interactions of oral semaglutide with omeprazole (40 mg once-daily) in fifty-four healthy subjects...
June 13, 2018: Expert Opinion on Drug Metabolism & Toxicology
https://www.readbyqxmd.com/read/29897132/association-between-proton-pump-inhibitors-and-the-risk-of-hepatocellular-carcinoma
#18
Y-H J Shao, T-S Chan, K Tsai, S-Y Wu
BACKGROUND: Proton pump inhibitor (PPI) use has been reported to be associated with liver damage and might possibly be carcinogenic. AIMS: We examined whether long-term PPI use increases the risk of hepatocellular carcinoma (HCC) in patients without viral hepatitis B or C. METHODS: We conducted a nested case-control study in a cohort of patients without viral hepatitis in Taiwan from 2000 to 2013. In total, 29 473 HCC cases and 294 508 matched controls were included...
June 13, 2018: Alimentary Pharmacology & Therapeutics
https://www.readbyqxmd.com/read/29892570/management-of-gastroesophageal-reflux-disease-in-adults-a-pharmacist-s-perspective
#19
REVIEW
Brett MacFarlane
Gastroesophageal reflux disease (GERD) is a common gastrointestinal diagnosis, a leading reason for endoscopy and cause of potentially serious complications, resulting in significant individual and system-wide health burden. Approximately one quarter of people living in western countries have experienced GERD, and the prevalence appears to be on the rise. Risk factors for GERD include hiatus hernia, obesity, high-fat diet, tobacco smoking, alcohol consumption, pregnancy, genetics, and some medications. The cardinal symptoms of GERD are troublesome heartburn and regurgitation...
2018: Integrated Pharmacy Research and Practice
https://www.readbyqxmd.com/read/29888274/difference-between-the-upper-and-the-lower-gastrointestinal-bleeding-in-patients-taking-nonvitamin-k-oral-anticoagulants
#20
Kyohei Maruyama, Takatsugu Yamamoto, Hitoshi Aoyagi, Akari Isono, Koichiro Abe, Shinya Kodashima, Hiroto Kita, Yuji Watari, Ken Kozuma
Nonvitamin K oral anticoagulants (NOACs) sometimes cause hemorrhage, and the gastrointestinal tract is a common site of involvement. However, clinical characteristics of gastrointestinal bleeding (GIB) during NOAC therapy have not been fully elucidated. We studied 658 patients who were prescribed dabigatran, rivaroxaban, or apixaban between April 2011 and November 2015. Medical charts were reviewed to examine whether clinically relevant bleeding (Bleeding Academic Research Consortium criteria type 2 or greater) developed...
2018: BioMed Research International
keyword
keyword
22157
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"